PFIZER, INC.

DC

Pharmaceutical Company

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 28 of its records are shown together here.

Filings
665
Filed By
28
Reported In-House
$232,960,000
Reported By Firms
$27,489,333

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2021 PFIZER INC. 1st Quarter (Jan 1 - Mar 31)
AMENDED
$3,160,000
2021 AVOQ, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2021 PFIZER INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$2,980,000
2021 THEGROUP DC, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$80,000
2021 NVG, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2021 ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2021 THE DUBERSTEIN GROUP INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2021 ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report (No Activity)
—
2021 EMPIRE CONSULTING GROUP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2021 MARSHALL & POPP, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
Page 1 of 5  ·  43 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings